Phase 1 dose-escalation study of momelotinib, a Janus kinase 1/2 inhibitor, combined with gemcitabine and nab-paclitaxel in patients with previously untreated metastatic pancreatic ductal adenocarcinoma.
| Image |  |
|---|---|
| Description | scientific article published on 30 July 2018 |
| Author/s |
author: David A Barbie William C Hahn Kimmie Ng Charles S. Fuchs |
| Publication date | July 30, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |